VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | Exciting updates in MF: novel targets and agents

Lucia Masarova, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares some exciting updates and novel agents to look out for in myelofibrosis (MF), including navitoclax, parsaclisib, and imetelstat. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter